Table 4.
Multivariate linear regression analyses of AL elongation and ocular parameters with ortho-k.
| Parameter | Unadjusted model* | Adjusted model 1* | Adjusted model 2* | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Standardized beta | Beta (95% CI) | P-value | Standardized beta | Beta (95% CI) | P-value | Standardized beta | Beta (95% CI) | P-value | |
| ∆ Total aberration | 0.085 | 0.012 (− 0.028 to 0.053) | 0.552 | 0.211 | 0.019 (− 0.014 to 0.062) | 0.167 | 0.192 | 0.027 (− 0.009 to 0.064) | 0.142 |
| ∆ HOAs | − 0.366 | − 0.260 (− 0.430 to − 0.090) | 0.003 | − 0.283 | − 0.202 (− 0.360 to − 0.043) | 0.013 | − 0.331 | − 0.236 (− 0.403 to − 0.068) | 0.006 |
| ∆ horizontal coma | − 0.284 | − 0.132 (− 0.210 to − 0.055) | 0.001 | − 0.262 | − 0.122 (− 0.194 to − 0.051) | 0.001 | − 0.209 | − 0.097 (− 0.171 to − 0.024) | 0.010 |
| corneal peripheral defocus | − 0.287 | − 0.033 (− 0.056 to − 0.010) | 0.006 | − 0.364 | − 0.042 (− 0.064 to − 0.020) | 0.000 | − 0.318 | − 0.037 (− 0.058 to − 0.015) | 0.001 |
| TZ diameter | 0.275 | 0.145 (0.048 to 0.243) | 0.004 | 0.294 | 0.155 (0.066 to 0.245) | 0.001 | 0.261 | 0.138 (0.050 to 0.226) | 0.003 |
CI confidence interval, PD pupil diameter, AL axial length, HOAs higher-order aberrations, TZ treatment zone.
*In adjusted model 1, age and sex were adjusted; in adjusted model 2, PD, AL, and SE were adjusted based on model 1.